Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial
Nom du journal : Target Oncol
Année : 2014
Volume : 9
Page de départ : 273
Page de fin : 277